Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' NARA PL' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 42 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Kohler, H; Muller, S; Schiffer, M; Nara, PL
      Few clues for AIDS vaccines from structural data on gp120 and its receptors and antibodies

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY
    2. Tsai, WP; Kung, HF; Nara, PL
      The presence and absence of histocompatibility antigens in HIV type 1 produced by autologous blood-derived macrophages and peripheral blood lymphoblasts

      AIDS RESEARCH AND HUMAN RETROVIRUSES
    3. Nara, PL
      Deceptive imprinting: Insights into mechanisms of immune evasion and vaccine development

      ADVANCES IN VETERINARY MEDICINE, VOL 41
    4. WU SC; SPOUGE JL; NARA PL
      INCREASE OF PRIMARY HIV-1 PRODUCTION IN HUMAN PERIPHERAL-BLOOD MONONUCLEAR-CELLS BY INTERMITTENT MEDIUM REPLENISHMENT

      Biotechnology progress
    5. NARA PL
      AN OUNCE OF PREVENTION

      Vaccine
    6. NARA PL; GARRITY R
      DECEPTIVE IMPRINTING - A COSMOPOLITAN STRATEGY FOR COMPLICATING VACCINATION

      Vaccine
    7. SHANKARAPPA R; GUPTA P; LEARN GH; RODRIGO AG; RINALDO CR; GORRY MC; MULLINS JI; NARA PL; EHRLICH GD
      EVOLUTION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ENVELOPE SEQUENCES IN INFECTED INDIVIDUALS WITH DIFFERING DISEASE PROGRESSION PROFILES

      Virology
    8. MULLER S; MARGOLIN DH; NARA PL; ALVORD WG; KOHLER H
      STIMULATION OF HIV-1-NEUTRALIZING ANTIBODIES IN SIMIAN HIV-IIIB-INFECTED MACAQUES

      Proceedings of the National Academy of Sciences of the United Statesof America
    9. TSAI WP; RIMELZWAAN GF; MERGES MJ; WU SC; CONLEY S; KUNG HF; GARRITY R; GOUDSMIT J; NARA PL
      PRELIMINARY FINDINGS OF AN IN-VITRO HUMAN SPLEEN MONONUCLEAR CELL-CULTURE SYSTEM FOR PRIMARY ISOLATES OF HIV TYPE-1

      AIDS research and human retroviruses
    10. BOYD MR; GUSTAFSON KR; MCMAHON JB; SHOEMAKER RH; OKEEFE BR; MORI T; GULAKOWSKI RJ; WU L; RIVERA MI; LAURENCOT CM; CURRENS MJ; CARDELLINA JH; BUCKHEIT RW; NARA PL; PANNELL LK; SOWDER RC; HENDERSON LE
      DISCOVERY OF CYANOVIRIN-N, A NOVEL HUMAN IMMUNODEFICIENCY VIRUS-INACTIVATING PROTEIN THAT BINDS VIRAL SURFACE ENVELOPE GLYCOPROTEIN GP120 -POTENTIAL APPLICATIONS TO MICROBICIDE DEVELOPMENT

      Antimicrobial agents and chemotherapy
    11. GARRITY RR; RIMMELZWAAN G; MINASSIAN A; TSAI WP; LIN G; DEJONG JJ; GOUDSMIT J; NARA PL
      REFOCUSING NEUTRALIZING ANTIBODY-RESPONSE BY TARGETED DAMPENING OF ANIMMUNODOMINANT EPITOPE

      The Journal of immunology
    12. AHLERS JD; DUNLOP N; ALLING DW; NARA PL; BERZOFSKY JA
      CYTOKINE-IN-ADJUVANT STEERING OF THE IMMUNE-RESPONSE PHENOTYPE TO HIV-1 VACCINE CONSTRUCTS - GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR AND TNF-ALPHA SYNERGIZE WITH IL-12 TO ENHANCE INDUCTION OF CYTOTOXIC T-LYMPHOCYTES

      The Journal of immunology
    13. HUANG XL; BARCHI JJ; LUNG EDT; ROLLER PP; NARA PL; MUSCHIK J; GARRITY RR
      GLYCOSYLATION AFFECTS BOTH THE 3-DIMENSIONAL STRUCTURE AND ANTIBODY-BINDING PROPERTIES OF THE HIV-1(IIIB) GP120 PEPTIDE RP135

      Biochemistry
    14. AHLERS JD; DUNLOP N; PENDLETON CD; NEWMAN M; NARA PL; BERZOFSKY JA
      CANDIDATE HIV TYPE-1 MULTIDETERMINANT CLUSTER PEPTIDE-P18MN VACCINE CONSTRUCTS ELICIT TYPE-1 HELPER T-CELLS, CYTOTOXIC T-CELLS, AND NEUTRALIZING ANTIBODY, ALL USING THE SAME ADJUVANT IMMUNIZATION

      AIDS research and human retroviruses
    15. WU SC; SPOUGE JL; MERGES MJ; CONLEY SR; NARA PL
      A CYTOPATHIC INFECTIVITY ASSAY OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1IN HUMAN PRIMARY MACROPHAGES

      Journal of virological methods
    16. TSAI WP; CONLEY SR; KUNG HF; GARRITY RR; NARA PL
      PRELIMINARY IN-VITRO GROWTH-CYCLE AND TRANSMISSION STUDIES OF HIV-1 IN AN AUTOLOGOUS PRIMARY-CELL ASSAY OF BLOOD-DERIVED MACROPHAGES AND PERIPHERAL-BLOOD MONONUCLEAR-CELLS

      Virology
    17. SHANKARAPPA B; NICHOLAS HB; GUPTA P; RINALDO CR; GORRY MC; NARA PL; EHRLICH GD
      GENOTYPIC CLUSTERING OF THE INFECTING QUASI-SPECIES AND INCREASED VARIABILITY AT LATER TIME POINTS ARE ASSOCIATED WITH A MORE RAPID DECLINEOF CD4-1 INFECTION( CELL NUMBERS IN HIV)

      The FASEB journal
    18. VANCOTT TC; POLONIS VR; LOOMIS LD; MICHAEL NL; NARA PL; BIRX DL
      DIFFERENTIAL ROLE OF V3-SPECIFIC ANTIBODIES IN NEUTRALIZATION ASSAYS INVOLVING PRIMARY AND LABORATORY-ADAPTED ISOLATES OF HIV TYPE-1

      AIDS research and human retroviruses
    19. NARA PL
      OTHER DETERMINANTS OF HIV-1 ENTRY

      AIDS research and human retroviruses
    20. WARNER GL; DRUMMOND JE; NARA PL; ARTHUR LO; WATERS DJ
      SYNTHETIC PEPTIDE COMPETITION ELISA PREDICTS AN ANTISERUMS ABILITY TONEUTRALIZE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 IN A LAB-STRAIN SPECIFIC MANNER

      AIDS research and human retroviruses
    21. BINLEY JM; DITZEL HJ; PARREN PHW; HENDRY RM; SAWYER LSW; DUNLOP N; NARA PL; BARBAS CF; BURTON DR
      CLONING AND CHARACTERIZATION OF A LARGE PANEL OF ANTIBODIES TO GP41

      Journal of cellular biochemistry
    22. WU SC; SPOUGE JL; CONLEY SR; TSAI WP; MERGES MJ; NARA PL
      HUMAN PLASMA ENHANCES THE INFECTIVITY OF PRIMARY HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ISOLATES IN PERIPHERAL-BLOOD MONONUCLEAR-CELLS AND MONOCYTE-DERIVED MACROPHAGES

      Journal of virology
    23. GIRARD M; MEIGNIER B; BARRESINOUSSI F; KIENY MP; MATTHEWS T; MUCHMORE E; NARA PL; WEI Q; RIMSKY L; WEINHOLD K; FULTZ PN
      VACCINE-INDUCED PROTECTION OF CHIMPANZEES AGAINST INFECTION BY A HETEROLOGOUS HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1

      Journal of virology
    24. HARIHARAN K; NARA PL; SHABAZZ LA; MCCUTCHAN JA; KANG CY
      ANALYSIS OF B-CELL REPERTOIRE SPECIFIC TO THE NEUTRALIZING EPITOPES OF GLYCOPROTEIN-120 IN HIV-INFECTED INDIVIDUALS

      AIDS research and human retroviruses
    25. BERZOFSKY JA; AHLERS JD; SHIRAI M; PENDLETON CD; TAKESHITA T; DUNLOP N; MINASSIAN A; NEWMAN M; NARA PL
      CONSTRUCTION OF CANDIDATE SYNTHETIC PEPTIDE VACCINES FOR HIV-1

      AIDS research and human retroviruses
    26. BERZOFSKY JA; AHLERS JD; SHIRAI M; PENDLETON CD; TAKESHITA T; DUNLOP N; MINASSIAN A; NEWMAN M; NARA PL
      CONSTRUCTION OF CANDIDATE SYNTHETIC PEPTIDE VACCINES FOR HIV-1

      AIDS research and human retroviruses
    27. MERGES MJ; LAYNE SP; SPOUGE JL; NARA PL
      HIV-1 V3-SPECIFIC NEUTRALIZATION - VALENCY, REVERSIBILITY, AND THE STATE OF THE VIRION DETERMINE IN-VITRO EFFICACY

      AIDS research and human retroviruses
    28. SPOUGE JL; NARA PL; MERGES MJ; LAYNE SP
      VIRAL MULTIPLICITY OF ADSORPTION - A QUANTITATIVE ANALOG OF TARGET-CELL MULTIPLICITY INFECTION

      AIDS research and human retroviruses
    29. NARA PL; MERGES M; MUSSON S; CONLEY S; HOGERVORST E; GOUDSMIT J; HENDERSON L; ARTHUR L; DUNLOP N
      HUMAN PLASMA-PROTEINS AND HIV-1 - A MISSING LINK IN OUR UNDERSTANDINGOF THE PATHOBIOLOGY

      AIDS research and human retroviruses
    30. KOHLER H; MULLER S; NARA PL
      DECEPTIVE IMPRINTING IN THE IMMUNE-RESPONSE AGAINST HIV-1

      Immunology today
    31. BURTON DR; PYATI J; KODURI R; SHARP SJ; THORNTON GB; PARREN PWHI; SAWYER LSW; HENDRY RM; DUNLOP N; NARA PL; LAMACCHIA M; GARRATTY E; STIEHM ER; BRYSON YJ; CAO YZ; MOORE JP; HO DD; BARBAS CF
      EFFICIENT NEUTRALIZATION OF PRIMARY ISOLATES OF HIV-1 BY A RECOMBINANT HUMAN MONOCLONAL-ANTIBODY

      Science
    32. BARBAS CF; HU D; DUNLOP N; SAWYER L; CABABA D; HENDRY RM; NARA PL; BURTON DR
      IN-VITRO EVOLUTION OF A NEUTRALIZING HUMAN-ANTIBODY TO HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 TO ENHANCE AFFINITY AND BROADEN STRAIN CROSS-REACTIVITY

      Proceedings of the National Academy of Sciences of the United Statesof America
    33. KANG CY; HARIHARAN K; NARA PL; SODROSKI J; MOORE JP
      IMMUNIZATION WITH A SOLUBLE CD4-GP120 COMPLEX PREFERENTIALLY INDUCES NEUTRALIZING ANTI-HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ANTIBODIES DIRECTED TO CONFORMATION-DEPENDENT EPITOPES OF GP120

      Journal of virology
    34. LIN HJ; MYERS LE; YENLIEBERMAN B; HOLLINGER FB; HENRARD D; HOOPER CJ; KOKKA R; KWOK S; RASHEED S; VAHEY M; WINTERS MA; MCQUAY LJ; NARA PL; REICHELDERFER P; COOMBS RW; JACKSON JB
      MULTICENTER EVALUATION OF QUANTIFICATION METHODS FOR PLASMA HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 RNA

      The Journal of infectious diseases
    35. PINCUS SH; MESSER KG; NARA PL; BLATTNER WA; COLCLOUGH G; REITZ M
      TEMPORAL ANALYSIS OF THE ANTIBODY-RESPONSE TO HIV ENVELOPE PROTEIN INHIV-INFECTED LABORATORY WORKERS

      The Journal of clinical investigation
    36. LAYNE SP; DEMBO M; SPOUGE JL; GELDERBLOM HR; RENZ H; MERGES MJ; NARA PL
      FACTORS REGULATING THE SPONTANEOUS INACTIVATION OF HIV AND ITS SUSCEPTIBILITY TO NEUTRALIZATION

      Journal of acquired immune deficiency syndromes
    37. SPOUGE JL; LAYNE SP; DEMBO M; NARA PL
      SINGLE-HIT ANTIBODY KINETICS - THE RESOLUTION OF A PARADOX AND ITS IMPLICATIONS FOR VACCINE DEVELOPMENT

      Journal of acquired immune deficiency syndromes
    38. NARA PL; GARRITY R; MINASSIAN A; KANG C; MULLER S; KOHLER H; GOUDSMIT J
      HIV-1 INFECTION OF MAN - CONTROL AND REGULATION OF THE B-CELL RESPONSE THROUGH CLONAL DOMINANCE

      Journal of acquired immune deficiency syndromes
    39. CEASE KB; POTCOVA CA; GROENEVELD LM; PROBERT WS; DUNLOP NM; NARA PL
      MODULATION OF THE IMMUNE-RESPONSE TO HIV-1 ENVELOPE PROTEIN USING A MIXED IMMUNOGEN STRATEGY

      AIDS research and human retroviruses
    40. BACK NKT; SMIT L; SCHUTTEN M; NARA PL; TERSMETTE M; GOUDSMIT J
      MUTATIONS IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 GP41 AFFECT SENSITIVITY TO NEUTRALIZATION BY GP120 ANTIBODIES

      Journal of virology
    41. HARIHARAN K; NARA PL; POSNER MR; KANG CY
      IDENTIFICATION OF A NEW NEUTRALIZING EPITOPE CONFORMATIONALLY AFFECTED BY THE ATTACHMENT OF CD4 TO GP120

      The Journal of immunology
    42. AHLERS JD; PENDLETON CD; DUNLOP N; MINASSIAN A; NARA PL; BERZOFSKY JA
      CONSTRUCTION OF AN HIV-1 PEPTIDE VACCINE CONTAINING A MULTIDETERMINANT HELPER PEPTIDE LINKED TO A V3 LOOP PEPTIDE-18 INDUCING STRONG NEUTRALIZING ANTIBODY-RESPONSES IN MICE OF MULTIPLE MHC HAPLOTYPES AFTER 2 IMMUNIZATIONS

      The Journal of immunology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 16/02/20 alle ore 23:40:37